Active Biotech AB (publ) (LON:0GQU)

London flag London · Delayed Price · Currency is GBP · Price in SEK
0.0942
+0.0085 (9.92%)
At close: May 8, 2025
-20.71%
Market Cap 11.82M
Revenue (ttm) n/a
Net Income (ttm) -3.08M
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 50,000
Average Volume 68,543
Open 0.0942
Previous Close 0.0857
Day's Range 0.0942 - 0.0942
52-Week Range 0.0080 - 0.0090
Beta 0.49
RSI 57.55
Earnings Date May 8, 2025

About Active Biotech AB

Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat relapsed refractory multiple myeloma; Laquinimod, an immunomodulator that has completed phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an immunotherapy, which is in phase Ib/II study to treat patients with solid tumors. The company has... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Employees 6
Stock Exchange London Stock Exchange
Ticker Symbol 0GQU
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

There is no news available yet.